Dr. Haojie Wang, M.D.
What this data tells you about Dr. Wang
Dr. Haojie Wang is a cardiovascular disease in Dallas, TX, with 17 years in practice. Based on federal Medicare data, Dr. Wang performed 2,095 Medicare services across 1,537 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wang received a total of $23,452 from 25 pharmaceutical and/or device companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 341 | $84 | $238 |
| Anticoagulant management of patient taking warfarin | 330 | $8 | $41 |
| Electrocardiogram (EKG), 12-lead | 182 | $10 | $51 |
| Mri scan of heart before and after contrast | 141 | $94 | $441 |
| Mri scan of blood flow of heart | 133 | $9 | $43 |
| Echocardiogram, transthoracic | 99 | $142 | $729 |
| Ct scan of blood vessels and grafts of heart with contrast | 92 | $83 | $406 |
| Regadenoson injection (Lexiscan) for heart stress test | 92 | $45 | $224 |
| Heart muscle strain imaging | 66 | $28 | $139 |
| Injection, octafluoropropane microspheres, per ml | 66 | $29 | $126 |
| Blood draw (venipuncture) | 55 | $8 | $17 |
| Ultrasound of both sides of head and neck blood flow | 54 | $131 | $704 |
| Office visit, established patient, complex (40-54 min) | 46 | $125 | $335 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | $48 | $258 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 33 | $57 | $530 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 32 | $324 | $1,599 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $2 | $28 |
| Complete ultrasound study of arm and leg arteries | 25 | $15 | $96 |
| Ultrasound of heart, follow-up | 24 | $17 | $361 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $5 | $155 |
| Ultrasound of one leg arteries or artery grafts | 20 | $17 | $84 |
| New patient office visit (45-59 min) | 19 | $114 | $310 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $11 | $53 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $69 | $393 |
| Ultrasound study of arm and leg arteries | 17 | $9 | $44 |
| Initial hospital admission, high complexity | 16 | $136 | $517 |
| Hospital follow-up visit, high complexity | 16 | $93 | $268 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 15 | $26 | $122 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $13 | $85 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $12 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $17 | $79 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 11 | $50 | $243 |
| Electrocardiogram (ecg) 2-day continuous | 11 | $9 | $105 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wang is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 17%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with office visit, established patient (30-39 min)?
Does Dr. Wang receive payments from pharmaceutical companies?
How do Dr. Wang's costs compare to other cardiovascular diseases in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology